2024-02-06 18:24:05 ET
Inspire Medical Systems, Inc. (INSP)
Q4 2023 Earnings Conference Call
February 06, 2024 05:00 PM ET
Company Participants
Ezgi Yagci - Vice President of Investor Relations
Tim Herbert - President & Chief Executive Officer
Rick Buchholz - Chief Financial Officer
Conference Call Participants
Adam Maeder - Piper Sandler
Michael Sarcone - Jefferies
Danielle Antalffy - UBS
Richard Newitter - Truist Securities
David Rescott - Baird
Anthony Petrone - Mizuho Group
Brett Fishman - KeyBanc
Mike Kratky - Leerink Partners
Jon Block - Stifel
Suraj Kalia - Oppenheimer & Co
Presentation
Operator
Good afternoon. My name is Dilem, and I'll be your conference operator today. At this time, I'd like to welcome everyone to the Inspire Medical Systems Fourth Quarter and Full Year 2023 Conference Call. All lines have been placed on mute to prevent any background noise. After the speaker's remarks, there will be question-and-answer session.
I'll now hand the call over to your first speaker to Ezgi Yagci, the Vice President of Investor Relations at Inspire. You may begin the conference.
Ezgi Yagci
Thank you, Dilem, and thank you all for participating in today's call. Joining me are Tim Herbert, President and Chief Executive Officer; and Rick Buchholz, Chief Financial Officer. Earlier today, we released financial results for the 3 and 12 months ended December 31, 2023. A copy of the press release is available on our website.
On this call, management will make forward-looking statements within the meaning of the federal securities laws. All forward-looking statements, including, without limitation, those relating to our operations, financial results and financial condition, investments in our business, full year 2024 financial and operational outlook and changes in market access are based upon our current estimates and various assumptions.
These statements involve material risks and uncertainties that could cause actual results or events to materially differ. Accordingly, you should not place undue reliance on these statements.
Please see our filings with the Securities and Exchange Commission including our Form 10-K, which we plan to file with the SEC on February 9, 2024, for a description of these risks and uncertainties. Inspire disclaims any intention or obligation except as required by law, to update or revise any financial projections of forward-looking statements, whether because of new information, future events or otherwise. This conference call contains time-sensitive information and speaks only as of the live broadcast today, February 6, 2024.
With that, it is my pleasure to turn the call over to Tim Herbert. Tim?
Tim Herbert
Thank you, Ezgi. And thanks, everyone, for joining our business update call for the fourth quarter of 2023. We are excited to report our first quarter with operating income and a very strong finish to the year. We know our focus and discipline on patient outcomes and ensuring that each patient has the best possible experience with Inspire therapy is the foundation of our business and we remain committed to this as our top priority....
Read the full article on Seeking Alpha
For further details see:
Inspire Medical Systems, Inc. (INSP) Q4 2023 Earnings Call Transcript